000 01338 a2200373 4500
005 20250513035851.0
264 0 _c19951013
008 199510s 0 0 eng d
022 _a0950-1991
024 7 _a10.1242/dev.121.8.2303
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLandolt, R M
245 0 0 _aVersican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth.
_h[electronic resource]
260 _bDevelopment (Cambridge, England)
_cAug 1995
300 _a2303-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAxons
_xphysiology
650 0 4 _aCell Movement
_xphysiology
650 0 4 _aCells, Cultured
650 0 4 _aChick Embryo
650 0 4 _aChondroitin Sulfate Proteoglycans
_xbiosynthesis
650 0 4 _aFibroblasts
_xphysiology
650 0 4 _aImmunohistochemistry
650 0 4 _aLectins, C-Type
650 0 4 _aNeural Crest
_xcytology
650 0 4 _aRecombinant Proteins
650 0 4 _aVersicans
700 1 _aVaughan, L
700 1 _aWinterhalter, K H
700 1 _aZimmermann, D R
773 0 _tDevelopment (Cambridge, England)
_gvol. 121
_gno. 8
_gp. 2303-12
856 4 0 _uhttps://doi.org/10.1242/dev.121.8.2303
_zAvailable from publisher's website
999 _c7671227
_d7671227